Chow PKH, et al. - The safety, as well as efficacy of radioembolization (RE), was compared with that of sorafenib in patients with locally advanced hepatocellular carcinoma (HCC). Both treatment options did not provide significantly different overall survival. The improved toxicity profile of RE may inform treatment choice in selected patients.